Virtu Financial LLC Electro Core, Inc. Transaction History

Virtu Financial LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.21 - $5.63 $5,925 - $158,867	28,218 Added 52.72%	81,743 $21,000
Q3 2022 Nov 07, 2022	SELL	$0.46 - $6.75 $5,733 - $84,132	-12,464 Reduced 18.89%	53,525 $22,000
Q2 2022 Aug 09, 2022	SELL	$0.27 - $0.61 $6,759 - $15,272	-25,037 Reduced 27.51%	65,989 $34,000
Q1 2022 May 17, 2022	BUY	$0.5 - $0.88 $45,513 - $80,102	91,026 New	91,026 $53,000
Q4 2021 Feb 17, 2022	SELL	$0.58 - $1.09 $87,253 - $163,976	-150,437 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$0.93 - $1.18 $139,906 - $177,515	150,437 New	150,437 $170,000
Q2 2021 Sep 17, 2021	SELL	$1.19 - $2.06 $56,780 - $98,292	-47,715 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$1.62 - $3.05 $77,298 - $145,530	47,715 New	47,715 $98,000
Q4 2020 Feb 24, 2021	SELL	$1.44 - $1.98 $20,838 - $28,652	-14,471 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$0.8 - $2.33 $11,576 - $33,717	14,471 New	14,471 $25,000
Q2 2018 Jul 30, 2018	SELL	$16.51 - $19.85 $240,104 - $288,678	-14,543 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$16.51 - $19.85 $240,104 - $288,678	14,543 New	14,543 $243,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $1.12B
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.